Last Updated on September 24, 2026
Yes, there are rehab centers in Houston that accept patients who need medication-assisted treatment for opioid addiction. Nova Recovery Center operates outpatient addiction treatment programs in Houston that integrate medication-assisted treatment (MAT) with counseling, behavioral therapy, and recovery support for individuals with opioid use disorder. MAT combines FDA-approved medications like buprenorphine (Suboxone) or naltrexone with evidence-based psychosocial interventions to address both the physiological and psychological components of opioid dependence.
If you or someone you love needs more than detox, Nova Recovery Center also provides houston drug rehab.
Nova Recovery Center’s addiction treatment program program provides medically supervised, evidence-based care.
What Medication-Assisted Treatment Means for Opioid Addiction
Medication-assisted treatment is the clinical standard for opioid use disorder. It uses prescription medications to normalize brain chemistry, block the euphoric effects of opioids, relieve physiological cravings, and stabilize body systems without the negative effects of the original drug. When combined with behavioral therapy and recovery services, MAT reduces opioid use, overdose deaths, criminal activity, and infectious disease transmission more effectively than behavioral interventions alone.
The three FDA-approved medications for opioid use disorder are methadone, buprenorphine (commonly prescribed as Suboxone or Sublocade), and naltrexone (available as oral tablets or the monthly injection Vivitrol). Each works differently. Methadone and buprenorphine are opioid agonists or partial agonists that satisfy receptor activity without producing a high when taken as prescribed. Naltrexone is an opioid antagonist that blocks receptors entirely, preventing any opioid from producing euphoria.
Patients who need medication-assisted treatment for opioid addiction benefit most when the medication is part of a comprehensive treatment plan that includes individual counseling, group therapy, case management, and family support. Medication alone addresses withdrawal and craving but does not teach coping skills, repair relationships, or resolve co-occurring mental health conditions.
How Nova Recovery Center Delivers MAT in Houston
Nova Recovery Center’s Houston outpatient program provides medication-assisted treatment as part of a structured continuum of care. Patients meet with a prescribing physician or nurse practitioner who conducts a medical evaluation, reviews substance use history, and determines the appropriate medication and dosing protocol. Buprenorphine induction typically begins during the first clinical visit once the patient is in mild withdrawal, ensuring safe medication initiation without precipitating acute symptoms.
After medication stabilization, patients participate in scheduled therapy sessions that address the behavioral, emotional, and social dimensions of addiction. Treatment intensity varies by program level—intensive outpatient (IOP) typically involves nine or more hours per week of structured therapy, while standard outpatient care may be three to six hours weekly. The clinical team monitors medication response, adjusts dosing as needed, and coordinates with primary care providers or other specialists when medical or psychiatric complexity requires collaborative management.
Patients remain on their prescribed MAT medication for as long as it supports recovery stability. Some individuals continue indefinitely, which is consistent with current evidence and clinical guidelines. Others taper gradually under medical supervision after achieving sustained remission and building strong recovery supports. The decision is individualized and driven by patient goals, relapse risk, and clinical judgment—not arbitrary timelines or stigma.
Why Rehab Centers in Houston Accept MAT Patients
Rehab centers that accept patients who need medication-assisted treatment for opioid addiction recognize that MAT is the evidence-based standard of care. The Substance Abuse and Mental Health Services Administration (SAMHSA), the National Institute on Drug Abuse (NIDA), the American Society of Addiction Medicine (ASAM), and the World Health Organization all recommend MAT as first-line treatment for opioid use disorder. Programs that refuse MAT or require patients to taper off medications as a condition of admission operate outside current clinical guidelines and expose patients to preventable relapse and overdose risk.
Houston’s opioid crisis mirrors national trends. Fentanyl contamination has increased overdose fatality rates, shortened the window between use and death, and made abstinence-only approaches more dangerous than ever. Medication-assisted treatment reduces overdose mortality by 50 percent or more compared to behavioral treatment alone. Patients on buprenorphine or naltrexone have higher treatment retention, lower relapse rates, and better overall outcomes across every measured domain—employment, criminal justice involvement, housing stability, and family reunification.
Programs that integrate MAT also serve patients more effectively across the full spectrum of opioid use disorder severity. Individuals with long histories of use, prior treatment episodes, co-occurring mental health disorders, chronic pain, or polysubstance dependence often require pharmacological support to achieve early stabilization and engage meaningfully in therapy. Denying medication in these cases is not therapeutic rigor—it is clinical neglect.
Insurance Coverage and Payment for MAT in Houston
Nova Recovery Center accepts most major insurance plans and verifies benefits before admission to clarify coverage, copays, deductibles, and out-of-pocket responsibility. The Mental Health Parity and Addiction Equity Act requires most insurers to cover substance use disorder treatment, including medication-assisted treatment, at parity with medical and surgical benefits. Coverage typically includes physician visits, counseling sessions, medication costs, and laboratory monitoring such as urine drug screens.
Patients without insurance or with high deductibles may explore payment plans or other financial arrangements. Verification specialists can review plan documents, confirm in-network status, and estimate total cost based on the recommended level of care. Transparency in cost and coverage allows families to make informed decisions without surprise billing or hidden fees.
Medication costs vary by drug and formulation. Generic buprenorphine-naloxone is widely available and affordable under most pharmacy benefit plans. Brand-name Suboxone, Sublocade (monthly buprenorphine injection), and Vivitrol (monthly naltrexone injection) may have higher copays but offer adherence advantages for some patients. Prescribers discuss medication options, cost considerations, and insurance formularies during the initial assessment to match treatment with both clinical needs and financial reality.
What to Expect During MAT Intake and Assessment
Intake at Nova Recovery Center’s Houston location begins with a confidential phone conversation to assess immediate needs, answer questions, and schedule an evaluation. The clinical assessment includes a detailed substance use history, medical review, mental health screening, and discussion of treatment goals. Patients are asked about prior treatment episodes, withdrawal history, current medications, chronic health conditions, and social supports. Honesty during assessment ensures safe medication selection and appropriate level-of-care placement.
For patients currently using opioids, the medical team provides clear instructions about when to take the first dose of buprenorphine. Starting too soon can trigger precipitated withdrawal, an intensely uncomfortable reaction caused by displacing full opioid agonists from brain receptors. Patients must be in mild to moderate withdrawal—typically 12 to 24 hours after short-acting opioids like heroin or oxycodone, or 24 to 72 hours after long-acting opioids like methadone—before buprenorphine induction. The prescriber uses standardized withdrawal scales to confirm readiness and minimize discomfort.
Once stabilized on medication, patients begin their scheduled therapy sessions. Group therapy addresses relapse prevention, coping skills, triggers, and the neurobiological basis of addiction. Individual counseling explores trauma, family dynamics, co-occurring disorders, and personal recovery goals. Family sessions can be arranged when appropriate to rebuild trust, educate loved ones, and strengthen the home environment. Patients also receive case management support for housing, employment, legal issues, or healthcare coordination as needed.
Why MAT Works and What the Evidence Shows
Medication-assisted treatment works because opioid addiction is a chronic medical condition with a neurobiological foundation. Repeated opioid exposure alters brain reward circuits, stress response systems, and executive function. These changes persist long after detoxification and drive compulsive use despite consequences. Medication restores neurochemical balance, reduces craving intensity, and allows the brain’s recovery processes to proceed without the constant disruption of relapse.
Long-term studies show that patients who remain on MAT have significantly lower mortality rates than those who discontinue medication or never start. A 2018 study in Addiction found that the overdose death rate among patients who left buprenorphine treatment was nearly four times higher than among those who continued. Other research demonstrates improved quality of life, reduced HIV and hepatitis C transmission, decreased incarceration, and higher rates of employment and family stability among MAT patients.
Duration of treatment matters. Patients who remain in MAT for 12 months or longer have better outcomes than those who leave early. There is no maximum recommended duration—treatment continues as long as it supports recovery. Some patients remain on medication for years; others eventually taper. Both paths are valid when guided by clinical judgment and patient preference rather than arbitrary rules or stigma-driven timelines.
Choosing a Houston Rehab Center That Supports Your Recovery
When evaluating rehab centers in Houston that accept patients who need medication-assisted treatment for opioid addiction, ask specific questions about prescribing practices, medication options, counseling integration, and long-term support. Programs should offer all three FDA-approved medications or have a clear referral pathway if they do not prescribe methadone on-site. They should individualize treatment duration rather than impose fixed tapers. They should integrate medication with evidence-based therapies, not treat it as a standalone intervention.
Also ask about staff credentials. Prescribers should be licensed physicians, nurse practitioners, or physician assistants with DATA 2000 waivers (for buprenorphine) or appropriate DEA registration. Counselors and therapists should hold state licensure and have specialized training in addiction treatment and co-occurring disorders. Peer support staff bring lived experience that complements clinical expertise and can strengthen engagement and hope.
Finally, consider logistics—appointment availability, location accessibility, telehealth options, and coordination with work or family responsibilities. Nova Recovery Center offers flexible scheduling, evening and weekend sessions when available, and online intensive outpatient programming for patients who cannot attend in person. Treatment works best when it fits into real life rather than requiring patients to abandon employment, childcare, or other stabilizing commitments.
If you or someone you care about is struggling with opioid addiction and considering medication-assisted treatment, Nova Recovery Center’s Houston outpatient program can help. Reach out today to verify insurance, schedule an assessment, and begin the process of recovery with evidence-based medical and therapeutic support.
Ready to take the next step?
Nova Recovery Center provides inpatient and outpatient drug & alcohol rehab. Call (512) 893-6955 to speak with our team today.
